Tide preps for spring cleaning with latest addition
CINCINNATI — Procter & Gamble is introducing new Tide Oxi Multi-Purpose Stain Remover. The cleaner will hit shelves just in time for the annual spring cleaning tradition and will give consumers the ability to clean both in and out of the laundry room, the company said.
Tide Oxi can be used to clean everything from carpet and upholstery to bathtubs and patio furniture. Consumers also can use it as an additive to laundry detergent as an added stain fighter.
“Tide prides itself on offering the best laundry care products to make it easy to clean life’s messes,” said Karen Klei Schlosser, associate marketing director, P&G North American Fabric Care. “But we know that stains and spills happen outside the laundry room, too. That’s why we are excited to introduce a product that will allow for the deep-down Tide clean in the wash and around the house.”
Tide Oxi Multi-Purpose Stain Remover is available in Refreshing Breeze scent at retailers across the United States and carries a suggested retail price of $12.99 for a 7.5-lb tub.
AAFA releases top 100 allergy capitals
LANDOVER, Md. — Louisville, Ky., was named the No. 1 spring allergy capital, up from No. 5 last year, on Monday by the Asthma and Allergy Foundation of America.
Louisville earned top allergy honors because of its higher-than-average pollen counts, high use of allergy medicines by local patients and too few allergy specialists in the metro area, AAFA stated.
The southern and southeastern United States will be particularly bad for allergy sufferers. All 10 of the top 10 allergy cities are in these two regions:
- Louisville, Ky.;
- Memphis, Tenn.;
- Baton Rouge, La.;
- Oklahoma City;
- Jackson, Miss.;
- Chattanooga, Tenn.;
- Richmond, Va.;
- Birmingham, Ala.; and
- McAllen, Texas.
It’s the 12th year of the report, the AAFA noted.
Prasco to market authorized generic form of Evista
CINCINNATI — Prasco Labs on Tuesday announced that it has signed a marketing and distribution agreement with Eli Lilly and Co. to market the authorized generic version of Evista (raloxifene hydrochloride tablets), 60 mg strength, in the United States.
Evista is an estrogen agonist/antagonist used for the treatment and prevention of osteoporosis in postmenopausal women, the company said. It’s also used for the reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis and reduction in risk of invasive breast cancer in postmenopausal women who are at high risk for invasive breast cancer.
"Prasco continues to demonstrate our passion to bring high-quality, low-cost prescription drugs to consumers," said Prasco president and COO, David Vucurevich, R.Ph. "Evista represents our third Eli Lilly and Company Authorized Generic product launched, and we are very pleased to broaden that relationship.
Prasco will start shipping the product immediately. Financial terms of the agreement were not disclosed.